Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. (Q42457525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

14 March 2020

main subject

toll-like receptor

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jun Pin Shi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Jing Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Dong-Xue Bian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Xiao-Jie Ma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yun-Hao Xun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Wen-Jun Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yan Luo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yin-Lan Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ling Jia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yan Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ming-Li Zhu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

De-Wei Ye

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Gang Zhou

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Guo-Qiang Lou

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Pharmacology and Physiology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

482-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Epidemiology of non-alcoholic fatty liver disease in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Animal models of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Activin A inhibits activities of lipopolysaccharide-activated macrophages via TLR4, not of TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12241

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24739055%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference